Article
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma - Leukemia
Rating:
0.0
Views:
23
Likes:
1
Library:
1
B-cell maturation antigen (BCMA)-targeting chimeric antigen receptor (CAR) T cells revolutionized the treatment of relapsed/refractory multiple myeloma (RRMM). However, data on cellular (CAR) T cell dynamics and the association with response, resistance or the occurrence of cytokine release syndrome (CRS) are limited.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value